updating data for batch codes

docs/SymptomsCausedByDrugs/data/ProportionalReportingRatios/vaccines/575.json

@@ -1 +1 @@
-{"abnormal behaviour": 7.24, "accidental overdose": 6.85, "affect lability": 8.58, "aggression": 9.21, "agitation": 2.83, "altered state of consciousness": 2.81, "anger": 9.05, "arrhythmia": 2.13, "autism spectrum disorder": 7.29, "blood pressure decreased": 39.63, "bradycardia": 58.03, "depressed level of consciousness": 2.18, "depressed mood": 4.5, "disturbance in attention": 2.32, "disturbance in social behaviour": 44.18, "dizziness postural": 10.9, "electrocardiogram qt prolonged": 24.0, "enuresis": 68.36, "epilepsy": 2.81, "erectile dysfunction": 9.27, "gynaecomastia": 6.87, "hallucination": 5.68, "hallucination, auditory": 15.84, "hallucination, visual": 6.59, "heart rate decreased": 9.78, "hypotension": 7.78, "impulsive behaviour": 37.31, "increased appetite": 7.71, "intentional overdose": 7.29, "intentional product misuse": 2.26, "intentional product use issue": 4.9, "intentional self-injury": 4.22, "irritability": 2.36, "lethargy": 2.03, "loss of consciousness": 3.1, "medication error": 3.11, "mental impairment": 3.13, "middle insomnia": 6.87, "orthostatic hypotension": 7.65, "pallor": 3.42, "peripheral coldness": 2.51, "product availability issue": 62.0, "product dose omission issue": 3.05, "product residue present": 10.66, "product use issue": 3.08, "psychomotor hyperactivity": 8.71, "raynaud's phenomenon": 10.6, "restlessness": 2.43, "sedation": 8.13, "self-destructive behaviour": 14.02, "sinus bradycardia": 6.64, "somnolence": 11.24, "suicidal ideation": 6.95, "suicide attempt": 3.78, "syncope": 7.07, "thirst": 4.72, "tic": 40.37, "weight increased": 3.61, "withdrawal syndrome": 6.71, "wrong technique in product usage process": 2.7}
+{"acute kidney injury": 2.44, "addison's disease": 40.18, "adrenal insufficiency": 28.27, "adrenocortical insufficiency acute": 14.32, "adrenocorticotropic hormone deficiency": 43.62, "alanine aminotransferase increased": 2.04, "amylase increased": 2.7, "aplasia pure red cell": 3.14, "aplastic anaemia": 3.52, "arthritis": 5.38, "atrioventricular block complete": 4.07, "autoimmune colitis": 233.15, "autoimmune haemolytic anaemia": 14.86, "autoimmune hepatitis": 50.15, "autoimmune nephritis": 146.49, "autoimmune pancreatitis": 47.14, "autoimmune thyroiditis": 19.65, "capillary leak syndrome": 9.45, "cardiogenic shock": 3.42, "cholestasis": 2.41, "chronic gastritis": 8.17, "clostridium difficile infection": 3.22, "colitis": 73.2, "cortisol decreased": 12.6, "cutaneous vasculitis": 4.06, "dermatitis": 7.02, "diabetes mellitus": 3.18, "diabetic ketoacidosis": 5.39, "diarrhoea": 2.08, "diarrhoea haemorrhagic": 2.44, "drug eruption": 2.22, "drug reaction with eosinophilia and systemic symptoms": 4.88, "drug-induced liver injury": 4.33, "duodenitis": 21.99, "encephalitis": 9.42, "encephalitis autoimmune": 17.68, "encephalopathy": 2.07, "endocrine disorder": 33.49, "enteritis": 15.08, "enterocolitis": 14.73, "eosinophilia": 2.64, "fulminant type 1 diabetes mellitus": 29.79, "gastritis": 3.73, "general physical health deterioration": 2.14, "giant cell arteritis": 6.06, "glucocorticoid deficiency": 90.8, "guillain-barre syndrome": 4.88, "haemophagocytic lymphohistiocytosis": 12.11, "hepatic cytolysis": 3.52, "hepatitis": 40.76, "hepatotoxicity": 23.26, "hypercalcaemia": 3.13, "hyperthyroidism": 21.88, "hypertransaminasaemia": 15.03, "hypophysitis": 349.95, "hypopituitarism": 67.22, "hypothalamo-pituitary disorder": 15.74, "hypothyroidism": 15.19, "immune thrombocytopenia": 5.36, "immune-mediated adrenal insufficiency": 25.67, "immune-mediated adverse reaction": 25.47, "immune-mediated arthritis": 50.07, "immune-mediated dermatitis": 65.09, "immune-mediated encephalitis": 192.09, "immune-mediated enterocolitis": 204.07, "immune-mediated gastritis": 89.85, "immune-mediated hepatic disorder": 22.19, "immune-mediated hepatitis": 250.11, "immune-mediated hyperthyroidism": 36.12, "immune-mediated hypophysitis": 543.02, "immune-mediated hypothyroidism": 31.25, "immune-mediated lung disease": 76.79, "immune-mediated myasthenia gravis": 67.1, "immune-mediated myocarditis": 141.39, "immune-mediated myositis": 85.33, "immune-mediated nephritis": 175.02, "immune-mediated neuropathy": 103.24, "immune-mediated pancreatitis": 52.19, "immune-mediated thyroiditis": 223.03, "immune-mediated uveitis": 146.81, "infusion related reaction": 2.45, "intentional product use issue": 27.45, "intestinal perforation": 9.34, "iridocyclitis": 21.07, "kidney transplant rejection": 4.87, "large intestine perforation": 15.23, "lichenoid keratosis": 14.42, "lipase increased": 5.04, "liver disorder": 2.01, "lymphocytic hypophysitis": 379.78, "malignant neoplasm progression": 21.92, "meningitis": 4.02, "meningitis aseptic": 7.64, "metastases to central nervous system": 11.93, "metastases to liver": 2.47, "metastases to lung": 4.73, "metastases to lymph nodes": 2.93, "metastatic malignant melanoma": 12.91, "myasthenia gravis": 19.54, "myasthenic syndrome": 34.09, "myocarditis": 6.13, "myopathy": 6.51, "myositis": 21.34, "nephritis": 24.58, "nephropathy toxic": 2.64, "non-small cell lung cancer": 9.68, "off label use": 2.72, "optic neuritis": 5.32, "orbital myositis": 117.77, "pemphigoid": 6.81, "peritonitis": 3.27, "pneumonitis": 24.15, "polyarthritis": 8.3, "polymyalgia rheumatica": 3.67, "polyneuropathy": 5.53, "prescribed overdose": 4.75, "prescribed underdose": 3.95, "pulmonary toxicity": 4.76, "radiation necrosis": 80.04, "radiculopathy": 6.57, "rash maculo-papular": 4.8, "sarcoidosis": 10.82, "secondary adrenocortical insufficiency": 47.41, "sjogren's syndrome": 12.59, "skin toxicity": 15.08, "thyroid disorder": 4.35, "thyroiditis": 61.01, "toxic epidermal necrolysis": 8.85, "transaminases increased": 3.11, "tubulointerstitial nephritis": 17.57, "tumour pseudoprogression": 45.48, "type 1 diabetes mellitus": 32.48, "uveitis": 7.57, "vasculitis": 3.17, "vitiligo": 79.88, "vogt-koyanagi-harada disease": 26.82}